financetom
Business
financetom
/
Business
/
Catalent Acquisition by Novo Holdings Nearly Complete After Regulatory Hurdles Cleared
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Catalent Acquisition by Novo Holdings Nearly Complete After Regulatory Hurdles Cleared
Dec 16, 2024 4:23 AM

07:11 AM EST, 12/16/2024 (MT Newswires) -- Catalent ( CTLT ) and Novo Nordisk's ( NVO ) parent company Novo Holdings said Monday that they have completed all regulatory closing conditions for Novo's pending acquisition of Catalent ( CTLT ).

The deal to take Catalent ( CTLT ) private under Novo is now expected to close in the coming days, the companies said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Booking, Peerspace Launch Partnership Targeting Event Organizers
Booking, Peerspace Launch Partnership Targeting Event Organizers
Mar 13, 2024
09:18 AM EDT, 03/13/2024 (MT Newswires) -- Booking Holdings ( BKNG ) and Peerspace have launched a partnership focusing on event organizers, Peerspace said Wednesday. Event organizers who book a venue on Peerspace and confirmed attendees will get a discount on hotels and rental cars on Booking.com, the company said. The discount is valid for clients in the US, Australia,...
Sector Update: Consumer Stocks Slip Pre-Bell Wednesday
Sector Update: Consumer Stocks Slip Pre-Bell Wednesday
Mar 13, 2024
09:18 AM EDT, 03/13/2024 (MT Newswires) -- Consumer stocks were slipping pre-bell Wednesday with the Consumer Staples Select Sector SPDR Fund (XLP) recently down 0.2% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) declining by 0.3%. Dollar Tree ( DLTR ) was down nearly 14% after it issued fiscal Q1 earnings per share guidance that missed consensus...
Takeda Pharmaceutical Says Mezagitamab Phase 2 Trial Shows 'Positive' Results in Primary Immune Thrombocytopenia Patients
Takeda Pharmaceutical Says Mezagitamab Phase 2 Trial Shows 'Positive' Results in Primary Immune Thrombocytopenia Patients
Mar 13, 2024
09:15 AM EDT, 03/13/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) said Wednesday that interim analysis from a phase 2 trial of mezagitamab, which is intended for persistent or chronic primary immune thrombocytopenia, showed higher platelet response rates compared with placebo across all three dose cohorts. The company said the trial tested three different doses of subcutaneous mezagitamab against...
AT&T to Buy Carbon Removal Credits from 1PointFive Facility
AT&T to Buy Carbon Removal Credits from 1PointFive Facility
Mar 13, 2024
09:16 AM EDT, 03/13/2024 (MT Newswires) -- AT&T ( T ) has agreed to buy carbon dioxide removal credits from a 1PointFive direct air capture facility that is under construction in Texas, the companies said on Wednesday. The facility is designed to capture up to 500,000 metric tons of carbon dioxide yearly when fully operational, the companies said. The captured...
Copyright 2023-2026 - www.financetom.com All Rights Reserved